Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Juvenile myoclonic epilepsy with multiple sclerosis: Is there a dual role for valproate?
Ocular motor signatures of cognitive dysfunction in multiple sclerosis.
Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS.
[Vitamin D in Multiple Sclerosis].
Evidence of extensive RNA oxidation in normal appearing cortex of multiple sclerosis brain.
Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences Expert Panel Workshop.
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders.
[Co-authorship and collaboration networks in Spanish research into multiple sclerosis (1996-2010)].
Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients.
Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis.
Central defects of autonomic function in secondary progressive multiple sclerosis: observations based on cardiovascular and growth hormone responses to clonidine.
The effect of plasma exchange on serum anti-JC virus antibodies.
Chronic cerebrospinal venous insufficiency in multiple sclerosis: a highly prevalent age-dependent phenomenon.
Traumatic injury and multiple sclerosis: a systematic review and meta-analysis.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
State vocational rehabilitation services and employment in multiple sclerosis.
Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System.
Cannabinoids: Medical implications.
Psychiatric comorbidity in multiple sclerosis: It's not the genes.
Increased relapse activity for multiple sclerosis natalizumab users who become nonpersistent: a retrospective study.
Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
Biomarker time out.
Advances in the treatment of relapsing - Remitting multiple sclerosis.
Neurologic indications for therapeutic plasma exchange: 2013 update.

Pages